JP2018521030A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521030A5
JP2018521030A5 JP2017564358A JP2017564358A JP2018521030A5 JP 2018521030 A5 JP2018521030 A5 JP 2018521030A5 JP 2017564358 A JP2017564358 A JP 2017564358A JP 2017564358 A JP2017564358 A JP 2017564358A JP 2018521030 A5 JP2018521030 A5 JP 2018521030A5
Authority
JP
Japan
Prior art keywords
immunogenic composition
poly
acid
methacrylonitrile
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017564358A
Other languages
English (en)
Japanese (ja)
Other versions
JP6912394B2 (ja
JP2018521030A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/036461 external-priority patent/WO2016200951A1/en
Publication of JP2018521030A publication Critical patent/JP2018521030A/ja
Publication of JP2018521030A5 publication Critical patent/JP2018521030A5/ja
Priority to JP2021113391A priority Critical patent/JP7269285B2/ja
Application granted granted Critical
Publication of JP6912394B2 publication Critical patent/JP6912394B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017564358A 2015-06-12 2016-06-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤 Active JP6912394B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021113391A JP7269285B2 (ja) 2015-06-12 2021-07-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562175081P 2015-06-12 2015-06-12
US62/175,081 2015-06-12
PCT/US2016/036461 WO2016200951A1 (en) 2015-06-12 2016-06-08 Formulations for small intestinal delivery of rsv and norovirus antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021113391A Division JP7269285B2 (ja) 2015-06-12 2021-07-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤

Publications (3)

Publication Number Publication Date
JP2018521030A JP2018521030A (ja) 2018-08-02
JP2018521030A5 true JP2018521030A5 (enExample) 2020-05-07
JP6912394B2 JP6912394B2 (ja) 2021-08-04

Family

ID=57503876

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017564358A Active JP6912394B2 (ja) 2015-06-12 2016-06-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤
JP2021113391A Active JP7269285B2 (ja) 2015-06-12 2021-07-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021113391A Active JP7269285B2 (ja) 2015-06-12 2021-07-08 Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤

Country Status (12)

Country Link
US (3) US11433146B2 (enExample)
EP (2) EP3307239B1 (enExample)
JP (2) JP6912394B2 (enExample)
KR (2) KR102678401B1 (enExample)
CN (2) CN118045170A (enExample)
AU (1) AU2016274599B2 (enExample)
CA (1) CA2988761A1 (enExample)
DK (1) DK3307239T3 (enExample)
EA (1) EA201792512A1 (enExample)
ES (1) ES2832504T3 (enExample)
WO (1) WO2016200951A1 (enExample)
ZA (1) ZA201708434B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens
AU2018206304A1 (en) * 2017-01-06 2019-07-04 Stabilitech Biopharma Ltd Virus
WO2019104439A1 (en) * 2017-11-30 2019-06-06 Medicago Inc. Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins
CN108904795B (zh) * 2018-08-29 2022-07-05 温氏食品集团股份有限公司 一种猪流行性腹泻病毒的口服疫苗的制备方法
US20210311600A1 (en) * 2020-04-06 2021-10-07 Kirk David Bacon Seat Selection Application For Social Distancing Compliance
WO2024193965A1 (en) * 2023-03-17 2024-09-26 Glaxosmithkline Biologicals Sa Rsv-f-encoding nucleic acids

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152413A (en) 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
US4520019A (en) 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4579945A (en) 1982-04-29 1986-04-01 Ribi Immunochem Research, Inc. Purification of trehalose dimycolates
US4505899A (en) 1982-05-26 1985-03-19 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4505900A (en) 1982-05-26 1985-03-19 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5811128A (en) 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
ES2109362T3 (es) * 1991-06-21 1998-01-16 Univ Cincinnati Unas proteinas administrables oralmente y metodo para hacerlas.
JPH08505625A (ja) 1993-01-11 1996-06-18 ダナ−ファーバー キャンサー インスティチュート 細胞毒性ｔリンパ球応答の誘導
US6224911B1 (en) 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
WO1995003035A1 (en) 1993-07-23 1995-02-02 Massachusetts Institute Of Technology Polymerized liposomes with enhanced stability for oral delivery
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
CN1176658A (zh) 1994-10-24 1998-03-18 蛇药制品有限公司 治疗和预防艰难梭菌疾病的疫苗和抗毒素
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6676935B2 (en) 1995-06-27 2004-01-13 Cell Genesys, Inc. Tissue specific adenoviral vectors
AU4133397A (en) 1996-10-28 1998-05-22 Pfizer Inc. Oral vaccines for young animals with an enteric coating
FR2759293B1 (fr) 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6328967B1 (en) 1998-03-12 2001-12-11 Allergenics, Inc. Delivery system to modulate immune response
GB9818591D0 (en) 1998-08-27 1998-10-21 Danbiosyst Uk Pharmaceutical composition
US7264771B2 (en) 1999-04-20 2007-09-04 Baxter International Inc. Method and apparatus for manipulating pre-sterilized components in an active sterile field
US6355270B1 (en) 1999-01-11 2002-03-12 The Regents Of The University Of California Particles for oral delivery of peptides and proteins
AU783099B2 (en) 2000-01-07 2005-09-22 Rohm Gmbh & Co. Kg Selective activation of a TH1 or TH2 lymphocyte regulated immune response
AU2003240978A1 (en) 2002-05-31 2003-12-19 Genteric, Inc. Multi-functional polyamines for delivery of biologically-active polynucleotides
WO2004020592A2 (en) 2002-08-30 2004-03-11 Genteric, Inc. Retroductal salivary gland genetic vaccination
GB2407500A (en) 2003-11-03 2005-05-04 Ist Superiore Sanita Use of microparticles for antigen delivery
US20060128653A1 (en) 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of decitabine
TW200626185A (en) 2004-12-17 2006-08-01 Bpsi Holdings Inc Enteric film coating composition containing entericpolymer micronized with detackifier
CN103122360A (zh) 2006-02-28 2013-05-29 瓦克萨特公司 嵌合腺病毒载体
DE102006060799A1 (de) * 2006-12-21 2008-06-26 RUHR-UNIVERSITäT BOCHUM RSV F-Protein und seine Verwendung
JP2009298707A (ja) 2008-06-11 2009-12-24 Ohara Yakuhin Kogyo Kk 粒子加工方法
WO2010002418A2 (en) 2008-07-01 2010-01-07 The Johns Hopkins University Quick-dissolving oral thin film for targeted delivery of therapeutic agents
AU2009322285B2 (en) 2008-12-03 2016-07-28 Bausch Health Ireland Limited Formulations of guanylate cyclase C agonists and methods of use
US20120276167A1 (en) 2009-07-13 2012-11-01 Vaxgene Corporation Immunoprotection by oral administration of recombinant lactococcus lactis mini-capsules
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
EP2477652B1 (en) 2009-09-16 2015-04-15 Vaxart, Inc. Immunization strategy to prevent h1n1 infection
US20130273154A1 (en) 2011-03-02 2013-10-17 Joseph M. Fayad Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetes
US20130195800A1 (en) * 2010-03-23 2013-08-01 Intrexon Corporation Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
CA2804501C (en) * 2010-07-06 2021-01-26 Novartis Ag Noro virus derived immunogenic compositions and methods
CN103153289B (zh) 2010-08-25 2016-08-31 格兰特·鲁弗斯·斯柏林二世 改进型肠溶活性物质给药
US9370528B2 (en) 2011-03-02 2016-06-21 Volant Holdings Gmbh Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
AU2013243971B2 (en) 2012-04-04 2017-01-05 Vaxform Llc Improved adjuvant system for oral vaccine adminstration
IL247301B (en) 2014-02-20 2022-07-01 Vaxart Inc Formulations for small intestinal delivery
EP3307239B1 (en) 2015-06-12 2020-09-16 Vaxart, Inc. Formulations for small intestinal delivery of rsv and norovirus antigens

Similar Documents

Publication Publication Date Title
Nollenberger et al. Poly (meth) acrylate-based coatings
JP5847303B2 (ja) 医薬品剤形又は機能性食品剤形に適したコーティング組成物
Nikam et al. Eudragit a versatile polymer: a review
JP2009504710A5 (enExample)
KR101799625B1 (ko) 제약 또는 기능식품 투여 형태에 적합한 코팅 조성물
HRP20230305T1 (hr) Pripravci za ileo-jejunalnu dostavu lijeka
JP2017504590A5 (enExample)
BG105061A (bg) Ентерично покрит фармацевтичен състав и метод за получаване
JP2008522989A5 (enExample)
JP2010526110A (ja) 薬剤を加速放出する腸溶コーティングを含む固体剤形
EA201892836A1 (ru) Составы 2-[3-[4-амино-3-(2-фтор-4-феноксифенил)пиразол[3,4-d]пиримидин-1-ил]пиперидин-1-карбонил]-4-метил-4-[4-(оксетан-3-ил)пиперазин-1-ил]пент-2-еннитрила с модифицированным высвобождением
JP2016532655A5 (enExample)
CZ223495A3 (en) Materials for coatings and binding agents for medicament forms and the use of copolymer water dispersions
JP6659922B2 (ja) 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
RU2010153904A (ru) Ниацин-содержащие композиции с модифицированным высвобождением
JP2015512441A5 (enExample)
JP2018534280A5 (enExample)
JP2015120756A5 (enExample)
Tan et al. Investigation for the quality factors on the tablets containing medicated pellets
CN114845700A (zh) Otf的可溶性背衬层
JP2017506265A5 (enExample)
JP5534643B2 (ja) 多層剤形
JP2021169480A (ja) Ｒｓｖおよびノロウイルス抗原の小腸送達のための製剤
IL272933B2 (en) Preparation of solid dosage forms comprising antibodies by solution/ suspension layering
AR071970A1 (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla